Evaluate the Efficacy and Safety of ADCV01 As an Add-On Treatment for Primary Glioblastoma Multiforme (GBM) Patients
Clinical trial NCT04115761 · RECRUITING
Trial details
- NCT number
- NCT04115761
- Sponsor
- Ever Supreme Bio Technology Co., Ltd.
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-06-06
- Primary completion
- 2026-12-30
- Enrollment
- 24
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.